about
Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein traffickingBionanotechnology and the future of glioma.Bovine milk-derived exosomes for drug delivery.Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyCaveolin-1 and CDC42 mediated endocytosis of silica-coated iron oxide nanoparticles in HeLa cellsOverview of the role of nanotechnological innovations in the detection and treatment of solid tumors.Nanotherapeutics in the EU: an overview on current state and future directions.Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.Potential applications of nanoshells in biomedical sciences.Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors.Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases.Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications.Poly ɛ-caprolactone nanoparticles loaded with Uncaria tomentosa extract: preparation, characterization, and optimization using the Box-Behnken design.Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug.Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.Energy Dispersive X-ray (EDX) microanalysis: A powerful tool in biomedical research and diagnosis.Tc-99m and Fluorescence-Labeled Anti-Flt1 Peptide as a Multimodal Tumor Imaging Agent Targeting Vascular Endothelial Growth Factor-Receptor 1Camouflaged Nanosilver with Excitation Wavelength Dependent High Quantum Yield for Targeted TheranosticPhotodynamic Therapy for Metastatic Melanoma Treatment: A Review
P2860
Q27011482-64B3CB28-8997-4808-BE40-DD5627123D35Q30417964-74930C43-35FE-48B6-A48D-6E3F99F39D01Q30696706-70247930-F44E-43EB-A282-A9DC65C3DD1EQ30847079-B951728B-D652-44BD-ABA6-A60419E41B18Q33859472-9B240CBB-E067-4B97-9B3D-F413D913B9B0Q35031165-F8959EAD-FB23-4500-B210-52A33558964FQ37525035-71262CE8-89B9-41D0-8B3C-DB2B1BC718D6Q37601242-089CEBBA-56A3-4B1F-8D95-5912B37CC4C9Q37623841-20812A94-2DA4-4BED-9F19-40000662AE5FQ38105404-E7D44010-FE56-46B3-BF73-99B31B8C410BQ38149992-EE7F43CF-43D0-47CB-B3C3-34BCFADFD9CDQ38387165-26D735E9-F354-457C-81A5-D3226F253433Q38637311-66F68878-3F49-4622-98DD-46380DB05385Q39106653-3EC83828-4F37-4B13-A16B-D15F608DBE0AQ41614195-CB447D61-A075-43B1-B584-6ACB53BF311FQ41843230-2D26121D-9FF4-417E-B6C3-7CACA5970CB6Q42373834-84337FAA-60D0-4B81-B0D9-04276888AF94Q43376055-4EAABA73-098F-4991-A908-AD980323EF0AQ50333044-CD1641BA-A76A-4F03-A615-710F468FF089Q55078799-A8F24BE2-2850-4E03-8E07-1E682E164228Q57820483-3D5196F2-0A63-4B1E-8600-B05A811C7891Q58602580-FDBC50AB-C03A-4773-BAE5-B04FD2F86469Q58786646-B7ABFA4F-CBCF-4DE0-9507-48CFD80F351F
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nanotechnology-based approaches in anticancer research
@ast
Nanotechnology-based approaches in anticancer research
@en
type
label
Nanotechnology-based approaches in anticancer research
@ast
Nanotechnology-based approaches in anticancer research
@en
prefLabel
Nanotechnology-based approaches in anticancer research
@ast
Nanotechnology-based approaches in anticancer research
@en
P2860
P50
P356
P1476
Nanotechnology-based approaches in anticancer research
@en
P2093
Ghazi A Damanhouri
Shazi Shakil
P2860
P304
P356
10.2147/IJN.S33838
P407
P577
2012-08-09T00:00:00Z